A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
← catalyst calendarSponsored by AbbVie (industry) · ABBV — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
161actual
Sites
12
Countries
China, Japan, Taiwan
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-03-29 | actual | When the study began enrolling |
| Primary completion | 2025-02-26 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-02-26 | actual | The whole study's end, after follow-up |
| First posted | 2024-03-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-26 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Glabellar Lines
Interventions
- Drug: AGN-151586
- Drug: Placebo
Primary outcomes
what the primary-completion date above is the date OFPercentage of Participants with a >= 2-Grade Improvement from Baseline on the Facial Wrinkle Scale with Asian (FWS-A) Guide According to Investigator Assessment of Glabellar Lines (GL) Severity at Maximum Frown
measured Day 7
Percentage of Participants with a >= 2-Grade Improvement from Baseline on the FWS-A Guide According to Participant Assessment of GL Severity at Maximum Frown
measured Day 7
Number of Participants with Adverse Events (AEs)
measured Up to approximately Day 84
Permalink · ABBV's whole pipeline · Catalyst calendar · Every registered study · What changed